Skip to main content
CNMD logo

CNMD

CONMED Corporation

$43.20

4.03%

Trade Ideas Performance

Latest Closed Trade Idea

$43.20

4.03%
Loading...
We are loading your data. Please wait a moment.

Sentiment

News

33

Social

1

About

Events of CONMED Corporation (CNMD)

Several events have impacted CONMED's stock price in the past six months. CONMED reported Q3 2025 sales with a year-over-year increase and announced a share repurchase program while suspending its quarterly cash dividend. The company announced its intent to exit its gastroenterology product lines. CONMED reported Q4 and full-year 2025 financial results and issued 2026 guidance. Todd Garner stepped down as CFO. CONMED announced Q1 2026 financial results and raised its outlook for full-year 2026 organic revenue growth. CONMED's stock has experienced a decline, and analysts have given it a consensus rating of "Reduce" or "Hold".

FAQ

Related Assets

Price action provided by Massive. Fundamentals, news and corporate events provided by FactSet. NLP support provided by Perplexity & Gemini. All data is provided for informational purposes only.

Make every trade make sense.

Sign up free. No card required. Three trade ideas a day, the AI analyst, the community - on us.

Get started for FREE (opens in new tab)
Edge Hound mobile app preview on iPhone

Join us and trade with people
who think like you.

The Edge Hound Discord is where serious self-directed investors talk strategy, share setups, and learn from each other. Free to join with any plan - including Free.

Free to join with any plan - including Free.

Join our Discord community (opens in new tab)
CONMED Corp. (CNMD) Live Stock Price, Chart & Financial News | Edge Hound